Jan Novak Selected Research

Leukemia Inhibitory Factor

2/2024	LIF/JAK2/STAT1 Signaling Enhances Production of Galactose-Deficient IgA1 by IgA1-Producing Cell Lines Derived From Tonsils of Patients With IgA Nephropathy.
5/2020	Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan Novak Research Topics

Disease

98	IGA Glomerulonephritis (IGA Nephropathy) 03/2024 - 08/2002
17	Proteinuria 01/2021 - 10/2007
16	Glomerulonephritis 11/2023 - 03/2004
12	Infections 05/2023 - 03/2005
12	Disease Progression 01/2022 - 01/2007
11	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 01/2007
9	Hematuria 05/2023 - 01/2011
8	Nephritis 10/2021 - 01/2007
7	Neoplasms (Cancer) 06/2024 - 03/2015
6	Renal Insufficiency (Renal Failure) 03/2024 - 10/2012
6	IgA Vasculitis (Purpura, Schoenlein Henoch) 10/2021 - 01/2007
6	Chronic Renal Insufficiency 01/2019 - 07/2008
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 11/2020
5	Inflammation (Inflammations) 01/2022 - 12/2012
4	Kidney Diseases (Kidney Disease) 01/2023 - 07/2010
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 05/2015
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2007 - 12/2002
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 08/2017
3	Heart Failure 08/2020 - 08/2016
2	Obstructive Sleep Apnea 02/2024 - 12/2014
2	Febrile Neutropenia 12/2023 - 11/2020
2	Neutropenia 12/2023 - 11/2020
2	Celiac Disease (Celiac Sprue) 11/2022 - 02/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 08/2016
2	Hypertension (High Blood Pressure) 01/2022 - 10/2014
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 09/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 08/2002
2	Lupus Nephritis 01/2014 - 02/2008
2	Immune Complex Diseases (Immune Complex Disease) 05/2013 - 05/2012
2	Purpura 07/2011 - 12/2007
1	Pneumonia (Pneumonitis) 12/2023
1	Sleep Deprivation 09/2023
1	Type 2 Diabetes Mellitus (MODY) 11/2022
1	Hypertrophy 10/2022
1	Atrial Fibrillation 01/2022
1	Leukemia 01/2022
1	Residual Neoplasm 01/2022

Drug/Important Bio-Agent (IBA)

75	Immunoglobulin A (IgA)IBA 03/2024 - 08/2002
43	galactosyl-deficient IgA1IBA 02/2024 - 03/2004
37	Antigen-Antibody Complex (Immune Complex)IBA 03/2024 - 08/2002
29	Polysaccharides (Glycans)IBA 03/2024 - 03/2004
28	Galactose (Galactopyranose)FDA LinkGeneric 03/2024 - 03/2004
24	Immunoglobulin G (IgG)IBA 03/2024 - 03/2005
17	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2007
16	AutoantibodiesIBA 03/2024 - 02/2011
14	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 03/2004
10	AutoantigensIBA 05/2023 - 09/2012
10	AntibodiesIBA 01/2019 - 02/2005
7	Proteins (Proteins, Gene)FDA Link 01/2016 - 08/2002
6	Complement System Proteins (Complement)IBA 03/2024 - 10/2012
5	Peptides (Polypeptides)IBA 01/2016 - 09/2006
4	AntigensIBA 11/2022 - 12/2002
4	CytokinesIBA 01/2022 - 10/2011
4	EnzymesIBA 02/2015 - 12/2007
3	Interleukin-6 (Interleukin 6)IBA 05/2023 - 07/2014
3	CreatinineIBA 10/2022 - 10/2014
3	LectinsIBA 07/2015 - 12/2007
3	AcetylgalactosamineIBA 01/2014 - 05/2007
2	HLA-DR Antigens (HLA-DR)IBA 06/2024 - 01/2022
2	Leukemia Inhibitory FactorIBA 02/2024 - 05/2020
2	Oncostatin MIBA 02/2024 - 05/2020
2	Azacitidine (5 Azacytidine)FDA Link 12/2023 - 10/2023
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2023 - 10/2023
2	Immunoglobulin M (IgM)IBA 11/2023 - 08/2017
2	4-nitroimidazoleIBA 05/2023 - 11/2020
2	venetoclaxIBA 01/2022 - 11/2020
2	Chlorambucil (Leukeran)FDA Link 01/2022 - 01/2019
2	ibrutinibIBA 01/2022 - 01/2019
2	obinutuzumabIBA 01/2022 - 01/2019
2	InterleukinsIBA 05/2020 - 01/2005
2	Rituximab (Mabthera)FDA Link 01/2018 - 04/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 03/2004
2	ProteomeIBA 12/2017 - 07/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2017 - 03/2004
2	MicroRNAs (MicroRNA)IBA 01/2017 - 03/2015
2	VaccinesIBA 07/2015 - 06/2010
2	Complement Factor H (Factor H)IBA 05/2015 - 11/2013
2	Angiotensin IIIBA 05/2015 - 03/2004
2	OligosaccharidesIBA 12/2014 - 09/2006
2	ImmunosorbentsIBA 12/2014 - 12/2007
1	Fc Receptors (Fc Receptor)IBA 03/2024
1	Phosphotransferases (Kinase)IBA 03/2024
1	IntegrinsIBA 03/2024
1	sparsentanIBA 03/2024
1	guadecitabineIBA 12/2023
1	Decitabine FDA Link 12/2023
1	glasdegibIBA 10/2023
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2023
1	SolutionsIBA 09/2023
1	Contrast MediaIBA 01/2022
1	Dexmedetomidine FDA Link 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022

Therapy/Procedure

21	Therapeutics 03/2024 - 03/2004
5	Drug Therapy (Chemotherapy) 10/2023 - 11/2016
2	Kidney Transplantation 01/2021 - 06/2017
2	Nephrectomy 04/2020 - 03/2004
2	Transplantation 01/2018 - 02/2013
2	Stem Cell Transplantation 01/2018 - 11/2016
1	Induction Chemotherapy 12/2023
1	Catheter Ablation 01/2022